1) Okumura K, Io H, Matsumoto M, et al. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients. Clin Nephrol. 2013 ; 79 : 7-14.
2) Matsumoto M, Io H, Furukawa M, et al. Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients. J Nephrol. 2012 ; 25.
3) Io H, Ro Y, Sekiguchi Y, et al. Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients. Perit Dial Int. 2010 ; 30 : 353-61.
4) 日本透析医学会. 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌. 2011 ; 44 : 337-425.
5) 日本透析医学会. 維持血液透析ガイドライン : 血液透析処方. 透析会誌. 2013 ; 46 : 606-9.
6) Wakabayashi K, Io H, Nakata J, et al. Effects of cardiac function with postoperative arteriovenous fistula blood flow in patients with hemodialysis. Blood Purif. 2017 ; 44 : 24-9.
7) Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community : a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998 ; 98 : 2282-9.
8) Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol. 2009 ; 4 Suppl 1 : S79-91.
9) Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction : A multiorgan roadmap. Circulation. 2016 ; 134 : 73-90.
10) Io H, Aizawa M, Funabiki K, et al. Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients : Efficacy and stability of long acting erythropoietin stimulating agents. Nephrology (Carlton). 2015 ; 20 Suppl 4 : 7-13.
11) Io H, Nakata J, Inoshita H, et al. Relationship among left ventricular hypertrophy, cardiovascular events, and preferred blood pressure measurement timing in hemodialysis patients. J Clin Med. 2020 ; 9.
12) Io H, Suzuki Y. Strategy for prevention of left ventricular remodeling in predialysis and dialysis patients. Contrib Nephrol. 2018 ; 196 : 13-21.
13) Ogawa T, Koeda M, Nitta K. Left ventricular diastolic dysfunction in end-stage kidney disease : Pathogenesis, diagnosis, and treatment. Ther Apher Dial. 2015 ; 19 : 427-35.
14) Urena-Torres P, D'Marco L, Raggi P, et al. Valvular heart disease and calcification in CKD : more common than appreciated. Nephrol Dial Transplant. 2020 ; 35 : 2046-53.
15) Ohara T, Hashimoto Y, Matsumura A, et al. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J. 2005 ; 69 : 1535-9.
16) Voelkl J, Lang F, Eckardt KU, et al. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci. 2019 ; 76 : 2077-91.
17) Hu MC, Shiizaki K, Kuro-o M, et al. Fibroblast growth factor 23 and Klotho : physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013 ; 75 : 503-33.
18) Kano T, Io H, Nakata J, et al. Impact of transferrin saturation and anemia on radial artery calcification in patients with end-stage kidney disease. Nutrients. 2022 ; 14.
19) Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients : a propensity score analysis. Lancet. 2016 ; 387 : 2218-25.
20) Yamamoto M, Watanabe Y, Tada N, et al. Transcatheter aortic valve replacement outcomes in Japan : Optimized CathEter vAlvular iNtervention (OCEAN) Japanese multicenter registry. Cardiovasc Revasc Med. 2019 ; 20 : 843-51.
21) Maeda K, Kuratani T, Torikai K, et al. Early outcomes in Japanese dialysis patients treated with transcatheter aortic valve implantation. Circ J. 2015 ; 79 : 2713-9.
22) 石川慶, 峰松佑輔, 楠本繁崇, 他. 維持透析患者に対するTAVI治療の現状. 大阪透析研究会会誌. 2022 ; 39 : 75-9.
23) Maeda K, Kuratani T, Mizote I, et al. Midterm outcomes of transcatheter aortic valve replacement in dialysis patients with aortic valve stenosis. Circ J. 2019 ; 83 : 1600-6.
24) Minamino-Muta E, Kato T, Morimoto T, et al. Causes of death in patients with severe aortic stenosis : An observational study. Sci Rep. 2017 ; 7 : 14723.